Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of Repeated CBD on Cannabis Abuse Liability and Analgesia
NCT07434895Phase 1Recruiting
- Start
- Aug 2026
- Primary completion
- Dec 2029
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of cannabidiol in cannabis use disorder (CUD) and pain (6 arms). Primary endpoints: Visual Analog Scale Drug Liking at Day 14 and Marijuana Purchase Task: Elasticity at Day 14. Started Aug 2026; status: recruiting.
02
Drugs
cannabidiol
03
Conditions
cannabis use disorder (CUD)pain
Beyond the preview
Go deeper on NCT07434895.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07434895.